UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges

Heart failure reviews, 2021-01, Vol.26 (1), p.35-45

2021

Volltextzugriff (PDF)

Prognostic implication of relative regional strain ratio in cardiac amyloidosis

Heart (British Cardiac Society), 2016-05, Vol.102 (10), p.748-754

2016

Volltextzugriff (PDF)

Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure

Journal of the American College of Cardiology, 2015-08, Vol.66 (6), p.659-666

2015

Volltextzugriff (PDF)

Implications of Serum Chloride Homeostasis in Acute Heart Failure (From ROSE-AHF)

The American journal of cardiology, 2017-01, Vol.119 (1), p.78-83

2017

Volltextzugriff (PDF)

Prognostic Comparison of Different Sensitivity Cardiac Troponin Assays in Stable Heart Failure

The American journal of medicine, 2015-03, Vol.128 (3), p.276-282

2015

Volltextzugriff (PDF)

Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF

Journal of cardiac failure, 2016-11, Vol.22 (11), p.884-890

2016

Volltextzugriff (PDF)

Disentangling Knots of Misfolded Proteins: Do We Really Know the Prognostic Implications of the Pathogenic V122I TTR Variant?

The American journal of cardiology, 2024-06, Vol.221, p.131-132

2024

Volltextzugriff (PDF)

A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure

The American heart journal, 2015-06, Vol.169 (6), p.806-812

2015

Volltextzugriff (PDF)

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT

ESC Heart Failure, 2021-04, Vol.8 (2), p.842-848

2021

Volltextzugriff (PDF)

Hyperkalemia in Heart Failure: Probably Not O“K”

Journal of the American Heart Association, 2018-06, Vol.7 (11), p.n/a

2018

Volltextzugriff (PDF)

Transient Hyponatremia during Hospitalization for Acute Heart Failure

The American journal of medicine, 2016-06, Vol.129 (6), p.620-627

2016

Volltextzugriff (PDF)

Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF

Journal of the American Heart Association, 2020-12, Vol.9 (24), p.e015752-e015752

2020

Volltextzugriff (PDF)

Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial

European journal of heart failure, 2017-02, Vol.19 (2), p.241-249

2017

Volltextzugriff (PDF)

More Than Meets the Eye: Defining the Prevalence, Pathophysiology, and Approach to Myocardial Iron Overload

The American journal of cardiology, 2024-05, Vol.219, p.38-43

2024

Volltextzugriff (PDF)

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score

Diabetes care, 2019-12, Vol.42 (12), p.2298-2306

2019

Volltextzugriff (PDF)

Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial

Journal of the American Heart Association, 2018-11, Vol.7 (21), p.e009664

2018

Volltextzugriff (PDF)

Validation of prognostic value of the hemodynamic gain index in different groups of patients undergoing exercise stress testing

American heart journal plus, 2022-06, Vol.18, p.100174, Article 100174

2022

Volltextzugriff (PDF)

Novel Biomarkers of Heart Failure: Do They Have Incremental Clinical Utility?

Journal of cardiac failure, 2016-04, Vol.22 (4), p.263-264

2016

Volltextzugriff (PDF)

Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction: Insights From the TOPCAT Trial

Circulation (New York, N.Y.), 2019-04, Vol.139 (15), p.1851-1853

2019

Volltextzugriff (PDF)

Identifying a low‐flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial

ESC Heart Failure, 2019-08, Vol.6 (4), p.613-620

2019

Volltextzugriff (PDF)

Uncommon Disease in a Rare Location: The Mystery of the Rapidly Progressive Cardiomyopathy

Circulation (New York, N.Y.), 2020-10, Vol.142 (16), p.1591-1595

2020

Volltextzugriff (PDF)

Does the “July effect” of new trainees at teaching hospitals impact outcomes for patients hospitalized with heart failure? Real-world analyses of more than half a million US admissions

American heart journal plus, 2022-01, Vol.13, p.100072, Article 100072

2022

Volltextzugriff (PDF)

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review

JACC CardioOncology, 2021-10, Vol.3 (4), p.488-505

2021

Volltextzugriff (PDF)

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers

ESC Heart Failure, 2020-10, Vol.7 (5), p.3049-3058

2020

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney

Circulation (New York, N.Y.), 2020-09, Vol.142 (11), p.1055-1058

2020

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

ThemaHeart Failure

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges

Prognostic implication of relative regional strain ratio in cardiac amyloidosis

Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure

Implications of Serum Chloride Homeostasis in Acute Heart Failure (From ROSE-AHF)

Prognostic Comparison of Different Sensitivity Cardiac Troponin Assays in Stable Heart Failure

Clinical Implications of Serum Albumin Levels in Acute Heart Failure: Insights From DOSE-AHF and ROSE-AHF

Disentangling Knots of Misfolded Proteins: Do We Really Know the Prognostic Implications of the Pathogenic V122I TTR Variant?

A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure

Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT

Hyperkalemia in Heart Failure: Probably Not O“K”

Transient Hyponatremia during Hospitalization for Acute Heart Failure

Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF

Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial

More Than Meets the Eye: Defining the Prevalence, Pathophysiology, and Approach to Myocardial Iron Overload

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score

Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial

Validation of prognostic value of the hemodynamic gain index in different groups of patients undergoing exercise stress testing

Novel Biomarkers of Heart Failure: Do They Have Incremental Clinical Utility?

Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction: Insights From the TOPCAT Trial

Identifying a low‐flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial

Uncommon Disease in a Rare Location: The Mystery of the Rapidly Progressive Cardiomyopathy

Does the “July effect” of new trainees at teaching hospitals impact outcomes for patients hospitalized with heart failure? Real-world analyses of more than half a million US admissions

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers

Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney

Aktive Filter

Suchergebnisse filtern